Enveric Biosciences, Inc. (ENVB)
5.44
-4.89
(-47.34%)
USD |
NASDAQ |
Dec 11, 16:00
5.97
+0.53
(+9.74%)
Pre-Market: 08:22
Enveric Biosciences Shareholders Equity (Quarterly): 3.456M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| AbbVie, Inc. | -2.642B |
| Pasithea Therapeutics Corp. | 12.21M |
| CEL-SCI Corp. | 7.025M |
| AIM ImmunoTech, Inc. | -6.077M |
| IGC Pharma, Inc. | 8.092M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 4.362M |
| Total Liabilities (Quarterly) | 0.9059M |
| Current Ratio | 4.561 |